Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Iranian Journal of Biotechnology|February 5, 2021
Cytoplasmic Chaperones Enhance Soluble Expression of Anti-EGFR huscFv in <i>Escherichia coli</i>Atefeh Nazari, Safar Farajnia, Seber Zahri, et al.Advanced Pharmaceutical Bulletin|January 20, 2017
Development of a Novel Human Single Chain Antibody Against EGFRVIII Antigen by Phage Display TechnologyLeila Rahbarnia, Safar Farajnia, Hossein Babaei, et al.Immunopharmacology and Immunotoxicology|August 2, 2014
Development trends for generation of single-chain antibody fragmentsSafar Farajnia, Vahideh Ahmadzadeh, Asghar Tanomand, et al.Current Pharmaceutical Design|October 7, 2020
Anti-cancer Immunotoxins, Challenges, and ApproachesMaryam Dashtiahangar, Leila Rahbarnia, Safar Farajnia, et al.Immunology Letters|December 17, 2016
Isolation and characterization of a novel human scFv inhibiting EGFR vIII expressing cancersLeila Rahbarnia, Safar Farajnia, Hossein Babaei, et al.Journal of Molecular Structure|September 21, 2022
Rational design of an anti-cancer peptide inhibiting CD147 / Cyp A interactionZahra Maani, Safar Farajnia, Leila Rahbarnia, et al.Biologicals : Journal of the International Association of Biological Standardization|August 14, 2016
Invert biopanning: A novel method for efficient and rapid isolation of scFvs by phage display technologyLeila Rahbarnia, Safar Farajnia, Hossein Babaei, et al.Journal of Drug Targeting|November 8, 2016
Evolution of phage display technology: from discovery to applicationLeila Rahbarnia, Safar Farajnia, Hossein Babaei, et al.Infectious Disorders Drug Targets|March 31, 2023
<i>In silico</i> Validation of <i>Pseudomonas aeruginosa</i> Exotoxin A Domain I Interaction with the Novel Human scFv AntibodyZahra Shadman, Samaneh Ghasemali, Safar Farajnia, et al.Protein Expression and Purification|June 15, 2016
Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR)Bahman Akbari, Safar Farajnia, Nosratollah Zarghami, et al.Pageof 4